Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/495711CD.svg?ark=w1%2F20260526%2F495711CD&value=id)](https://nobleid.org/work/w1/20260526/495711CD)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors